Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group-Reference-Cited by-同舟云学术

Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group

Published:2017-01 Issue:1 Volume:4 Page:e46-e55
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Peyrade Frédéric,Bologna Serge,Delwail Vincent,Emile Jean François,Pascal Laurent,Fermé Christophe,Schiano Jean-Marc,Coiffier Bertrand,Corront Bernadette,Farhat Hassan,Fruchart Christophe,Ghesquieres Herve,Macro Margaret,Tilly Hervé,Choufi Bachra,Delarue Richard,Fitoussi Olivier,Gabarre Jean,Haioun Corinne,Jardin Fabrice

Publisher

Elsevier BV

Subject

Hematology

Reference29 articles.

1. Increasing incidence of non-Hodgkin's lymphoma;Rabkin;Semin Hematol,1993

2. Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial;Peyrade;Lancet Oncol,2011

3. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60);Pfreundschuh;Lancet Oncol,2008

4. Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1–2 study;Coiffier;Blood,2008

5. First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial;Hagenbeek;Blood,2008

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of R‐CHOP‐14 and R‐mini‐CHOP in older adults with diffuse large B‐cell lymphoma—A retrospective multicenter cohort study;European Journal of Haematology;2024-07-31

2. Determination of the appropriate chemotherapy for patients aged 80 years or older with diffuse large B cell lymphoma;2024-06-12

3. Appropriate Treatment Intensity for Diffuse Large B-Cell Lymphoma in the Older Population: A Review of the Literature;Hematology Reports;2024-05-24

4. Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study;The Korean Journal of Internal Medicine;2024-05-01

5. Metronomic Chemotherapy in Elderly Patients;Current Oncology Reports;2024-03-07